Synapse - Hidenori Kitai

Hidenori Kitai

Groups

Sloan Kettering Institute Postdocs

Research Focus

Former Employee. MOLECULAR PHARMACOLOGY PROGRAM; Research Associate

Recent additions – View all

Combined inhibition of KRAS(G12C) and mTORC1 kinase is synergistic in non-small cell lung cancer
Journal Article

Kitai, H.; Choi, P. H.; Yang, Y. C.; Boyer, J. A.; Whaley, A.; Pancholi, P.; Thant, C.; Reiter, J.; Chen, K.; Markov, V.; more...
Nature Communications (2024)

Fulltext@MSK | Save
The bi-steric mTORC1-selective inhibitor RMC-5552 in tumors with activation of mTOR signaling: Preclinical activity in combination with RAS(ON) inhibitors in RAS-addicted tumors, and initial clinical findings from a single agent phase 1/1b study
Meeting Abstract

Burris, H. A. 3rd; Ulahannan, S. V.; Haura, E. B.; Ou, S. H. I.; Capasso, A.; Munster, P. N.; Kitai, H.; Wang, Z.; Hayes, J.; Tao, L.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save
WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC
Journal Article

Taniguchi, H.; Caeser, R.; Chavan, S. S.; Zhan, Y. A.; Chow, A.; Manoj, P.; Uddin, F.; Kitai, H.; Qu, R.; Hayatt, O.; more...
Cell Reports (2022)

Fulltext@MSK | Save

Co-authors at MSK

2

De Stan...
2

Rosen
2

Taniguchi
1

Allaj
1

Boyer
1

Caeser
1

Chan
1

Chavan
1

Chen
1

Choi
1

Chow
1

Hayatt
1

Manoj
1

Markov
1

Michel
1

Nguyen
1

Pancholi
1

Quintan...
1

Qu
1

Reiter
1

Rudin
1

Schram
1

Sen
1

Shah
1

Thant
1

Uddin
1

Whaley
1

Zhan

Types of Work

Publications